Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MEDP | Common Stock | Sale | -$2.57M | -12.1K | -0.21% | $212.10 | 5.84M | Nov 29, 2021 | Direct | F1, F2 |
transaction | MEDP | Common Stock | Sale | -$41.4K | -197 | 0% | $210.29 | 5.84M | Nov 30, 2021 | Direct | F1 |
Id | Content |
---|---|
F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. |
F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $214.345. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |